InsidersTradesSigma
Follow the 동화약품 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 동화약품 has published 1 insider filings. Market capitalisation: €147.7bn. The latest transaction was reported on 11 March 2026 (Other). Among the most active insiders: 동화약품. All data is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.